Logo image of ARA

American Renal Associates (ARA) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:ARA -

11.52
+0.02 (+0.17%)
Last: 1/25/2021, 8:04:00 PM

ARA Key Statistics, Chart & Performance

Key Statistics
Market Cap397.94M
Revenue(TTM)814.10M
Net Income(TTM)-9.04M
Shares34.54M
Float11.64M
52 Week High11.98
52 Week Low5.57
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.11
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
ARA short term performance overview.The bars show the price performance of ARA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60

ARA long term performance overview.The bars show the price performance of ARA in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20 25

The current stock price of ARA is 11.52 null. In the past month the price increased by 0.61%. In the past year, price increased by 26.87%.

American Renal Associates / ARA Daily stock chart

ARA Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to ARA. When comparing the yearly performance of all stocks, ARA turns out to be only a medium performer in the overall market: it outperformed 50.97% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ARA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ARA. ARA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ARA Financial Highlights

Over the last trailing twelve months ARA reported a non-GAAP Earnings per Share(EPS) of -0.10999999999999999. The EPS decreased by -57.38% compared to the year before.


Industry RankSector Rank
PM (TTM) -1.11%
ROA -0.78%
ROE N/A
Debt/Equity 7.54
Chartmill High Growth Momentum
EPS Q2Q%-124.24%
Sales Q2Q%-0.82%
EPS 1Y (TTM)-57.38%
Revenue 1Y (TTM)-1.23%

ARA Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y-142.31%
Revenue Next YearN/A

ARA Ownership

Ownership
Inst Owners0.01%
Ins Owners1.04%
Short Float %N/A
Short RatioN/A

About ARA

Company Profile

American Renal Associates Holdings, Inc. is a provider of dialysis services primarily in the United States. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. American Renal Associates Holdings, Inc. is based in Beverly, Massachusetts.

Company Info

American Renal Associates

500 CUMMINGS CENTER SUITE 6550

BEVERLY MA 01915

CEO: Joseph A. Carlucci

Phone: 978-922-3080

American Renal Associates / ARA FAQ

What does American Renal Associates do?

American Renal Associates Holdings, Inc. is a provider of dialysis services primarily in the United States. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. American Renal Associates Holdings, Inc. is based in Beverly, Massachusetts.


Can you provide the latest stock price for American Renal Associates?

The current stock price of ARA is 11.52 null. The price increased by 0.17% in the last trading session.


Does American Renal Associates pay dividends?

ARA does not pay a dividend.


What is the ChartMill rating of American Renal Associates stock?

ARA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


How is the valuation of American Renal Associates (ARA) based on its PE ratio?

American Renal Associates (ARA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).